… trials directly compared the relative efficacy of tyrosine kinase inhibitors (TKIs) in patients with
… Therefore, the aim of this study was to assess the overall survival (OS) of advanced EGFR-…

… A better suited drug treatment may be associated with improved outcomes. The aim of …
cohort study was to determine the real-world prescription rates of the various drugs used to treat …

… Study Design Among the population of patients with CML, we conducted a retrospective
cohort study … chronic phase who were receiving TKI treatment. All patients were followed from …

… With the widespread use of tyrosine kinase inhibitors (TKIs) for the treatment of patients with
chronic myeloid leukemia (CML), the risk of transformation to blast phase (BP) has markedly …

… Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are standard of care
for patients with EGFR mutation-positive non–small-cell lung cancer (NSCLC) with common …

… To reduce the selection bias inherent to retrospective cohort studies, we conducted
propensity score matching to control for potential confounders [34]. Baseline characteristics, …

… of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKI) (ICI+TKI) in 51
patients with advanced or metastatic renal cell carcinoma (mRCC). In this study, 7.0 months …

… -world cohorts of Asian patients with NSCLC. The present study aimed to analyze the treatment
efficacy of EGFR-TKIs and acquired T790M resistance in a large cohort of Asian patients …

… study, we investigated the use of EGFR TKIs and treatment outcomes in RWE settings using
a large nationwide cohort… for afatinib than gefitinib treated patients which was presumably …

… % of patients received brain imaging before treatment start. To our knowledge, this is one of
the largest cohort studies from Western Europe reporting real-world treatment effects of first-, …